GE Healthcare introduced the Discovery STE, the latest addition to the company's market leading modular PET/CT platform, at the 2005 Society of Nuclear Medicine (SNM) conference in Toronto. The new Discovery STE provides physicians with a wide range of clinically relevant capabilities and true hybrid imaging flexibility, allowing them the opportunity to diagnose patients with cancer, heart disease, and neurological conditions earlier and better and to monitor a patient's course of treatment.

GE was the first to commercially introduce PET/CT imaging in 2001, an advanced technology that integrates a Positron Emission Tomography (PET) system with a Computed Tomography (CT) system. To date, more than 500 GE Discovery PET/CT systems have been installed at medical facilities worldwide, including seven of the top ten cancer centers in the U.S.

The new Discovery STE system is an elite clinical performance configuration, built on the foundation of Discovery ST. Discovery STE delivers a balanced system design of high sensitivity, resolution and count-rate performance. Its powerful processing & acquisition capabilities make Discovery STE the ideal system for growing procedure demands in neurology and cardiology, without sacrificing the requirements of a premier oncology system.
"The scanner provides an incredible combination of performance specifications, one which compliments our tracer and clinical investigations," said Mika Teras Ph.D., Turku Imaging Laboratory Manager.

With the Discovery STE system, physicians are provided clinically relevant choices to image a broad range of patient population with a variety of clinical conditions.

With the Discovery STE system, physicians are provided clinically relevant choices to image a broad range of patient population with a variety of clinical conditions.

"Discovery STE provides the opportunity for us to ensure an excellent examination for any patient that enters our facility, regardless of their clinical imaging need," said Prof. Juhani Knuuti M.D., Director Turku PET Centre in Finland.

At the heart of the Discovery STE is the revolutionary Discovery Dimension Console, fully integrated to optimize PET/CT workflow. The new Discovery Dimension Console provides a wider range of choices to meet patient's clinical needs, enabling clinicians to:

* Acquire radiology prescription diagnostic IV Contrast CT images during the PET/CT study, so that patients are subjected to fewer exams and less dose.

More Industry Headlines